866-997-4948(US-Canada Toll Free)

Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2020-2026

Published By :

QYResearch

Published Date : Feb 2020

Category :

Healthcare

No. of Pages : 95 Pages

This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories

Market segment by Type, the product can be split into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application, split into
Household Contacts with Pulmonary TB
PLHIV
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tuberculin Skin Test (TST)
1.4.3 Interferon Gamma Released Assay (IGRA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2026
1.5.2 Household Contacts with Pulmonary TB
1.5.3 PLHIV
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2015-2026)
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Latent Tuberculosis Infection (LTBI) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Latent Tuberculosis Infection (LTBI) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Market Size
3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2015-2020)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
3.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2019
3.3 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.4 Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
3.5 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2015-2020)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2021-2026)

5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application (2015-2026)
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America (2019-2020)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe (2019-2020)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

8 China
8.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China (2019-2020)
8.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
8.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan (2019-2020)
9.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
9.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

11 India
11.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India (2019-2020)
11.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
11.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2015-2020)
12.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)
12.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Qiagen
13.1.1 Qiagen Company Details
13.1.2 Qiagen Business Overview and Its Total Revenue
13.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
13.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020))
13.1.5 Qiagen Recent Development
13.2 BioMerieux
13.2.1 BioMerieux Company Details
13.2.2 BioMerieux Business Overview and Its Total Revenue
13.2.3 BioMerieux Latent Tuberculosis Infection (LTBI) Testing Introduction
13.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.2.5 BioMerieux Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
13.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Danaher
13.4.1 Danaher Company Details
13.4.2 Danaher Business Overview and Its Total Revenue
13.4.3 Danaher Latent Tuberculosis Infection (LTBI) Testing Introduction
13.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.4.5 Danaher Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Latent Tuberculosis Infection (LTBI) Testing Introduction
13.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Becton Dickinson
13.6.1 Becton Dickinson Company Details
13.6.2 Becton Dickinson Business Overview and Its Total Revenue
13.6.3 Becton Dickinson Latent Tuberculosis Infection (LTBI) Testing Introduction
13.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.6.5 Becton Dickinson Recent Development
13.7 Agilent Technologies
13.7.1 Agilent Technologies Company Details
13.7.2 Agilent Technologies Business Overview and Its Total Revenue
13.7.3 Agilent Technologies Latent Tuberculosis Infection (LTBI) Testing Introduction
13.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.7.5 Agilent Technologies Recent Development
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Details
13.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.8.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
13.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.8.5 Bio-Rad Laboratories Recent Development
13.9 Eppendorf
13.9.1 Eppendorf Company Details
13.9.2 Eppendorf Business Overview and Its Total Revenue
13.9.3 Eppendorf Latent Tuberculosis Infection (LTBI) Testing Introduction
13.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.9.5 Eppendorf Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview and Its Total Revenue
13.10.3 Abbott Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
13.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables

Table 1. Latent Tuberculosis Infection (LTBI) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
Table 3. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tuberculin Skin Test (TST)
Table 6. Key Players of Interferon Gamma Released Assay (IGRA)
Table 7. Key Players of Others
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2015-2020)
Table 12. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Latent Tuberculosis Infection (LTBI) Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Latent Tuberculosis Infection (LTBI) Testing Players
Table 19. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2015-2020)
Table 21. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2019)
Table 22. Global Latent Tuberculosis Infection (LTBI) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
Table 25. Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2015-2020)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2015-2020)
Table 31. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 35. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 37. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 41. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 43. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 45. China Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 47. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 49. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 53. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 55. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 59. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 63. India Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 65. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 67. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2019-2020)
Table 71. Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2015-2020)
Table 73. Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2015-2020)
Table 75. Qiagen Company Details
Table 76. Qiagen Business Overview
Table 77. Qiagen Product
Table 78. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 79. Qiagen Recent Development
Table 80. BioMerieux Company Details
Table 81. BioMerieux Business Overview
Table 82. BioMerieux Product
Table 83. BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 84. BioMerieux Recent Development
Table 85. Thermo Fisher Scientific Company Details
Table 86. Thermo Fisher Scientific Business Overview
Table 87. Thermo Fisher Scientific Product
Table 88. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 89. Thermo Fisher Scientific Recent Development
Table 90. Danaher Company Details
Table 91. Danaher Business Overview
Table 92. Danaher Product
Table 93. Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 94. Danaher Recent Development
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Product
Table 98. Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 99. Roche Recent Development
Table 100. Becton Dickinson Company Details
Table 101. Becton Dickinson Business Overview
Table 102. Becton Dickinson Product
Table 103. Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 104. Becton Dickinson Recent Development
Table 105. Agilent Technologies Company Details
Table 106. Agilent Technologies Business Overview
Table 107. Agilent Technologies Product
Table 108. Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 109. Agilent Technologies Recent Development
Table 110. Bio-Rad Laboratories Business Overview
Table 111. Bio-Rad Laboratories Product
Table 112. Bio-Rad Laboratories Company Details
Table 113. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 114. Bio-Rad Laboratories Recent Development
Table 115. Eppendorf Company Details
Table 116. Eppendorf Business Overview
Table 117. Eppendorf Product
Table 118. Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 119. Eppendorf Recent Development
Table 120. Abbott Laboratories Company Details
Table 121. Abbott Laboratories Business Overview
Table 122. Abbott Laboratories Product
Table 123. Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020) (Million US$)
Table 124. Abbott Laboratories Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2020 VS 2026
Figure 2. Tuberculin Skin Test (TST) Features
Figure 3. Interferon Gamma Released Assay (IGRA) Features
Figure 4. Others Features
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2026
Figure 6. Household Contacts with Pulmonary TB Case Studies
Figure 7. PLHIV Case Studies
Figure 8. Others Case Studies
Figure 9. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2019
Figure 15. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2019
Figure 17. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 26. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. BioMerieux Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 28. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 30. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Danaher Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 34. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Becton Dickinson Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 36. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Agilent Technologies Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 38. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 40. Eppendorf Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eppendorf Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 42. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Abbott Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *